Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Gasche

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
Gut|May 22, 2015
Novel evidence for an oncogenic role of microRNA-21 in colitis-associated colorectal cancerChenzhang Shi, Yongzhi Yang, Yang Xia, et al.
Journal of Crohn'S & Colitis|May 14, 2013
Colorectal cancer in inflammatory bowel disease: results of the 3rd ECCO pathogenesis scientific workshop (I)Shaji Sebastian, Vincent Hernández, Pär Myrelid, et al.
Inflammatory Bowel Diseases|November 7, 2007
Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseasesChristoph Gasche, Arnold Berstad, Ragnar Befrits, et al.
Cancer Research|April 22, 2017
HuR Small-Molecule Inhibitor Elicits Differential Effects in Adenomatosis Polyposis and Colorectal CarcinogenesisMichaela Lang, David Berry, Katharina Passecker, et al.
Haematologica|May 7, 2015
On the safety of intravenous iron, evidence trumps conjectureMichael Auerbach, John Adamson, Andreas Bircher, et al.
Gut Microbes|November 22, 2022
Atypical enteropathogenic <i>E. coli</i> are associated with disease activity in ulcerative colitisMaximilian Baumgartner, Rebecca Zirnbauer, Sabine Schlager, et al.
BMJ Open|November 10, 2025
Mesalamine for Colorectal Cancer Prevention Programme in Lynch syndrome (MesaCAPP): a multicentre, multinational, randomised, two-arm, double-blind, phase II clinical study with mesalamine or placebo in carriers with Lynch syndrome - a study protocolAnn-Sofie Backman, Alexander Frank, Lars Joachim Lindberg, et al.
Gastroenterology|June 19, 2021
Mucosal Biofilms Are an Endoscopic Feature of Irritable Bowel Syndrome and Ulcerative ColitisMaximilian Baumgartner, Michaela Lang, Hunter Holley, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|September 10, 2005
Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of GastroenterologyMark S Silverberg, Jack Satsangi, Tariq Ahmad, et al.
The Journal of Experimental Medicine|June 5, 2025
Filamin A editing in myeloid cells reduces intestinal inflammation and protects from colitisRiem Gawish, Rajagopal Varada, Florian Deckert, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Gut|May 22, 2015
Novel evidence for an oncogenic role of microRNA-21 in colitis-associated colorectal cancerChenzhang Shi, Yongzhi Yang, Yang Xia, et al.
Journal of Crohn'S & Colitis|May 14, 2013
Colorectal cancer in inflammatory bowel disease: results of the 3rd ECCO pathogenesis scientific workshop (I)Shaji Sebastian, Vincent Hernández, Pär Myrelid, et al.
Inflammatory Bowel Diseases|November 7, 2007
Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseasesChristoph Gasche, Arnold Berstad, Ragnar Befrits, et al.
Cancer Research|April 22, 2017
HuR Small-Molecule Inhibitor Elicits Differential Effects in Adenomatosis Polyposis and Colorectal CarcinogenesisMichaela Lang, David Berry, Katharina Passecker, et al.
Haematologica|May 7, 2015
On the safety of intravenous iron, evidence trumps conjectureMichael Auerbach, John Adamson, Andreas Bircher, et al.
Gut Microbes|November 22, 2022
Atypical enteropathogenic <i>E. coli</i> are associated with disease activity in ulcerative colitisMaximilian Baumgartner, Rebecca Zirnbauer, Sabine Schlager, et al.
BMJ Open|November 10, 2025
Mesalamine for Colorectal Cancer Prevention Programme in Lynch syndrome (MesaCAPP): a multicentre, multinational, randomised, two-arm, double-blind, phase II clinical study with mesalamine or placebo in carriers with Lynch syndrome - a study protocolAnn-Sofie Backman, Alexander Frank, Lars Joachim Lindberg, et al.
Gastroenterology|June 19, 2021
Mucosal Biofilms Are an Endoscopic Feature of Irritable Bowel Syndrome and Ulcerative ColitisMaximilian Baumgartner, Michaela Lang, Hunter Holley, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|September 10, 2005
Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of GastroenterologyMark S Silverberg, Jack Satsangi, Tariq Ahmad, et al.
The Journal of Experimental Medicine|June 5, 2025
Filamin A editing in myeloid cells reduces intestinal inflammation and protects from colitisRiem Gawish, Rajagopal Varada, Florian Deckert, et al.
Pageof 11